Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
J Mol Diagn ; 23(7): 796-804, 2021 07.
Article in English | MEDLINE | ID: mdl-33962053

ABSTRACT

Real-time RT-PCR remains a gold standard in the detection of various viral diseases. In the coronavirus 2019 pandemic, multiple RT-PCR-based tests were developed to screen for viral infection. As an emergency response to increasing testing demand, we established a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR diagnostics platform for which we compared different commercial and in-house RT-PCR protocols. Four commercial, one customized, and one in-house RT-PCR protocols were evaluated with 92 SARS-CoV-2-positive and 92 SARS-CoV-2-negative samples. Furthermore, economical and practical characteristics of these protocols were compared. In addition, a highly sensitive digital droplet PCR (ddPCR) method was developed, and application of RT-PCR and ddPCR methods on SARS-CoV-2 environmental samples was examined. Very low limits of detection (1 or 2 viral copies/µL), high sensitivities (93.6% to 97.8%), and high specificities (98.7% to 100%) for the tested RT-PCR protocols were found. Furthermore, the feasibility of downscaling two of the commercial protocols, which could optimize testing capacity, was demonstrated. Tested commercial and customized RT-PCR detection kits show very good and comparable sensitivity and specificity, and the kits could be further optimized for use on SARS-CoV-2 viral samples derived from human and surface swabbed samples.


Subject(s)
COVID-19 Nucleic Acid Testing/methods , COVID-19/diagnosis , COVID-19/epidemiology , Pandemics , Real-Time Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain Reaction/methods , SARS-CoV-2/genetics , COVID-19/virology , False Negative Reactions , False Positive Reactions , Feasibility Studies , Humans , RNA, Viral/genetics , RNA, Viral/isolation & purification , Sensitivity and Specificity , Smartphone , Surface Properties , Switzerland/epidemiology
2.
J Wound Care ; 28(Sup6): S1-S92, 2019 06 01.
Article in English | MEDLINE | ID: mdl-31169055

Subject(s)
Wounds and Injuries/therapy , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/pathology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/therapy , Blood Coagulation Disorders/complications , Blood Coagulation Disorders/diagnosis , Blood Coagulation Disorders/pathology , Blood Coagulation Disorders/therapy , Calciphylaxis/complications , Calciphylaxis/diagnosis , Calciphylaxis/pathology , Calciphylaxis/therapy , Erythema Induratum/complications , Erythema Induratum/diagnosis , Erythema Induratum/pathology , Erythema Induratum/therapy , Factitious Disorders/complications , Factitious Disorders/diagnosis , Factitious Disorders/therapy , Hidradenitis Suppurativa/complications , Hidradenitis Suppurativa/diagnosis , Hidradenitis Suppurativa/pathology , Hidradenitis Suppurativa/therapy , Humans , IgA Vasculitis/complications , IgA Vasculitis/diagnosis , IgA Vasculitis/pathology , IgA Vasculitis/therapy , Livedo Reticularis/complications , Livedo Reticularis/diagnosis , Livedo Reticularis/pathology , Livedo Reticularis/therapy , Patient Care Team , Polyarteritis Nodosa/complications , Polyarteritis Nodosa/diagnosis , Polyarteritis Nodosa/pathology , Polyarteritis Nodosa/therapy , Pyoderma Gangrenosum/complications , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/pathology , Pyoderma Gangrenosum/therapy , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Skin Neoplasms/secondary , Skin Neoplasms/therapy , Vasculitis/complications , Vasculitis/diagnosis , Vasculitis/pathology , Vasculitis/therapy , Wounds and Injuries/diagnosis
3.
Case Rep Dermatol ; 11(1): 108-112, 2019.
Article in English | MEDLINE | ID: mdl-31123454

ABSTRACT

Terra firma-forme dermatosis (TFFD) is a little-known disease of unknown etiology that clinically presents with asymptomatic brown to black plaques and resembles dirty skin. Here, we report the case of a 38-year-old woman with skin changes on her areolae that were mistakenly diagnosed as "dermatitis neglecta" by several physicians. Cleansing with water and soap had no impact on the skin appearance. But a swab of 70% isopropyl alcohol removed the plaques immediately, which confirmed the diagnosis of TFFD. Only a few cases of TFFD have been published, and this skin condition is not mentioned in many textbooks. Given the unfamiliarity of this disease, TFFD is speculated to be immensely underdiagnosed, even though a simple diagnostic sign exists.

4.
Dermatol Ther ; 31(6): e12692, 2018 11.
Article in English | MEDLINE | ID: mdl-30246910

ABSTRACT

Pruritus is associated with various skin diseases, dry skin, and with it an impaired skin barrier function. The study objective was to investigate short-term and long-term effects of two emollients on symptoms and skin barrier functions in xerotic eczema. Randomized, double-blind, study enrolling females/males, with bilateral itching. Two emollients, containing lactic acid and refined almond oil with/without polidocanol were administered on left versus right body sides. Itching severity, skin moisture, lipid content, and pH were assessed on Day 1, within 30-120 min after first administration, and on Days 7 and 14, and compared with baseline assessments. Severity of itching decreased 30 min after first administration of both emollients compared with baseline (p < .0001) and reached a maximum reduction of 63% (p < .0001) and 69% (p < .0001) on Day 14. Skin moisture and lipid content increased after first application, and further ameliorated within 14 days of treatment (p < .0001). Both emollients were tolerated well, and only a few adverse events were reported. This study confirmed the clinical efficacy of the two study emollients to substantially reduce itching already after first administration, and restore skin barrier integrity and thus should be considered as therapeutic approach for xerotic eczema.


Subject(s)
Eczema/drug therapy , Emollients/administration & dosage , Lactic Acid/administration & dosage , Plant Oils/administration & dosage , Pruritus/drug therapy , Skin/drug effects , Administration, Cutaneous , Adolescent , Adult , Aged , Double-Blind Method , Drug Administration Schedule , Eczema/diagnosis , Eczema/physiopathology , Emollients/adverse effects , Female , Humans , Lactic Acid/adverse effects , Male , Middle Aged , Plant Oils/adverse effects , Polidocanol/administration & dosage , Pruritus/diagnosis , Pruritus/physiopathology , Skin/innervation , Skin/pathology , Switzerland , Time Factors , Treatment Outcome , Young Adult
5.
J Invest Dermatol ; 138(9): 2010-2023, 2018 09.
Article in English | MEDLINE | ID: mdl-29689250

ABSTRACT

Rare autosomal dominant mutations in the gene encoding the keratinocyte signaling molecule CARD14, have been associated with an increased susceptibility to psoriasis, but the physiological impact of CARD14 gain-of-function mutations remains to be fully determined in vivo. Here, we report that heterozygous mice harboring a CARD14 gain-of-function mutation (Card14ΔE138) spontaneously develop a chronic psoriatic phenotype with characteristic scaling skin lesions, epidermal thickening, keratinocyte hyperproliferation, hyperkeratosis, and immune cell infiltration. Affected skin of these mice is characterized by elevated expression of anti-microbial peptides, chemokines, and cytokines (including T helper type 17 cell-signature cytokines) and an immune infiltrate rich in neutrophils, myeloid cells, and T cells, reminiscent of human psoriatic skin. Disease pathogenesis was driven by the IL-23/IL-17 axis, and neutralization of IL-23p19, the key cytokine in maintaining T helper type 17 cell polarization, significantly reduced skin lesions and the expression of antimicrobial peptides and proinflammatory cytokines. Therefore, hyperactivation of CARD14 alone is sufficient to orchestrate the complex immunopathogenesis that drives T helper type 17-mediated psoriasis skin disease in vivo.


Subject(s)
CARD Signaling Adaptor Proteins/genetics , DNA/genetics , Gain of Function Mutation , Guanylate Kinases/genetics , Interleukin-17/metabolism , Interleukin-23/metabolism , Keratinocytes/metabolism , Psoriasis/genetics , Animals , CARD Signaling Adaptor Proteins/metabolism , Cells, Cultured , Cytokines/metabolism , DNA Mutational Analysis , Disease Models, Animal , Female , Guanylate Kinases/metabolism , Humans , Inflammation/genetics , Inflammation/metabolism , Inflammation/pathology , Keratinocytes/pathology , Membrane Proteins , Mice , Psoriasis/metabolism , Psoriasis/pathology
6.
Case Rep Dermatol ; 8(2): 224-226, 2016.
Article in English | MEDLINE | ID: mdl-27721755

ABSTRACT

A 74-year-old woman with extensive lichen planus mucosae (LPM) developed stenotic esophagitis that was refractory to intravenous glucocorticosteroids. Esophageal dilatations to 14 mm width were repeatedly performed without any lasting effect. After introducing oral apremilast, she experienced complete clinical remission within the first 4 weeks of treatment. Control esophagoscopy confirmed a marked recovery of the esophageal mucosa with no recurrence of the former stenosis. Our observation is in line with the case series of Paul et al. [J Am Acad Dermatol 2013;68: 255-261] who first reported on the benefit of apremilast in patients with extensive LPM. Ideally, the effectiveness of apremilast in LPM should be studied in a randomized controlled trial.

9.
J Dermatol ; 41(4): 329-33, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24612373

ABSTRACT

We report a 43-year-old woman, who underwent therapy with interferon-α for hairy cell leukemia. During interferon-α therapy she developed multiple subcutaneous swellings, accompanied by fever and fatigue. A skin biopsy revealed lobular, T-cell lymphocytic panniculitis. In conjunction with the clinical and immunological findings, the diagnosis of lupus panniculitis was made and interferon-α therapy stopped. Initially, she responded well to oral prednisone and hydroxychloroquine, but after several months she became resistant to it. Her condition worsened, she developed skin ulcers in the inflamed regions. Only with the leukemia-targeted therapy using cladribine and rituximab her skin condition could be controlled, suggesting hairy cell leukemia as an additional trigger of the lupus panniculitis. Our report is the first one to show induction of lupus panniculitis under interferon therapy of hairy cell leukemia and its presumable sustentation by the latter.


Subject(s)
Interferon-alpha/adverse effects , Leukemia, Hairy Cell/complications , Leukemia, Hairy Cell/drug therapy , Panniculitis, Lupus Erythematosus/etiology , Adult , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Cladribine/therapeutic use , Female , Humans , Hydroxychloroquine/therapeutic use , Panniculitis, Lupus Erythematosus/drug therapy , Panniculitis, Lupus Erythematosus/pathology , Rituximab
12.
Acta Derm Venereol ; 92(1): 24-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22041865

ABSTRACT

Interleukin-31 (IL-31) is a recently discovered cytokine expressed in many human tissues, and predominantly by activated CD4(+) T cells. IL-31 signals through a heterodimeric receptor consisting of IL-31 receptor alpha (IL-31RA) and oncostatin M receptor beta (OSMR). Earlier studies have shown involvement of IL-31 and its receptor components IL-31RA and OSMR in atopic dermatitis, pruritus and Th2-weighted inflammation at the mRNA level. The aim of this study was to investigate IL-31 protein expression in skin of such conditions. Immunohistochemical staining for IL-31, IL-31RA and OSMR was performed in formalin-fixed paraffin-embedded biopsy specimens. IL-31 expression was increased in the inflammatory infiltrates from skin biopsies taken from subjects with atopic dermatitis, compared with controls (p ≤ 0.05). IL-31, IL-31RA and OSMR protein immunoreactivity was not increased in biopsies from subjects with other Th2-weighted and pruritic skin diseases. Our results confirm, at the protein level, the relationship between IL-31 expression and atopic dermatitis. Our results do not support a general relationship between expression of IL-31/IL-31R and pruritic or Th2-mediated diseases.


Subject(s)
Dermatitis, Atopic/metabolism , Interleukins/metabolism , Pruritus/metabolism , Th2 Cells/metabolism , Alopecia Areata/metabolism , Analysis of Variance , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Dermatitis, Atopic/immunology , Humans , Immunohistochemistry , Interleukins/immunology , Leukocyte Common Antigens/metabolism , Mycosis Fungoides/metabolism , Oncostatin M Receptor beta Subunit/metabolism , Prurigo/metabolism , Pruritus/immunology , Psoriasis/metabolism , Receptors, Interleukin/metabolism , Sezary Syndrome/metabolism , Th2 Cells/immunology
13.
Photodermatol Photoimmunol Photomed ; 27(1): 51-2, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21198884

ABSTRACT

We report the case of an 81-year-old male patient who developed a reactivation of herpes simplex virus localized to the right forehead, where photodynamic therapy (PDT) for actinic keratosis was performed. Considering the wide use of PDT, herpes virus infection or reactivation as well as other infections seem to be a very rare but potentially serious complication that has to be distinguished from common inflammatory reactions after PDT. Further applications of PDT under antiviral prophylaxis were well tolerated by our patient, with no further herpetic reactivation and successful treatment of actinic keratoses.


Subject(s)
Antibiotic Prophylaxis , Herpes Simplex/etiology , Herpesvirus 1, Human/isolation & purification , Photochemotherapy/adverse effects , Acyclovir/analogs & derivatives , Acyclovir/therapeutic use , Aged, 80 and over , Antiviral Agents/therapeutic use , Herpes Simplex/drug therapy , Humans , Male , Recurrence , Valacyclovir , Valine/analogs & derivatives , Valine/therapeutic use
15.
Arch Dermatol ; 146(9): 961-8, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20855694

ABSTRACT

OBJECTIVES: To better define the diagnosis and treatment of Martorell hypertensive ischemic leg ulcer (HYTILU) and to compare Martorell HYTILU with calciphylaxis (calcific uremic arteriolopathy) and nonuremic forms of calciphylaxis. DESIGN: Retrospective study from 1999 through 2007. SETTING: Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland. PARTICIPANTS: Of 330 patients with leg ulcers, 31 had a clinical diagnosis of Martorell HYTILU confirmed by dermatopathologic examination. MAIN OUTCOME MEASURES: Clinical features, suspected diagnosis at initial presentation, cardiovascular risk factors, findings from vascular examination and histologic analysis, specific medical and surgical management, and outcome. RESULTS: Of the 31 patients, all presented with 1 or multiple painful necrotic skin ulcers on the laterodorsal part of the leg, with bilateral involvement in 16 of 31 cases (52%), and 16 were referred with suspected pyoderma gangrenosum. All patients had arterial hypertension, and 18 (58%) had diabetes. All patients had subcutaneous stenotic arteriolosclerosis on histologic analysis, with medial calcification in 22 of 31 of cases (71%). Martorell HYTILU, calciphylaxis, and nonuremic forms of calciphylaxis shared identical histologic features. Of the 31 patients, 29 (94%) were successfully treated with surgical debridement and split-thickness skin grafting. Three patients (9%) died of sepsis, 2 of whom were undergoing immunosuppressive treatment for wrongly diagnosed pyoderma gangrenosum. CONCLUSIONS: Ischemic subcutaneous arteriolosclerosis is the hallmark of Martorell HYTILU, calciphylaxis, and the nonuremic forms of calciphylaxis. All patients are hypertensive and approximately 60% are diabetic. Martorell HYTILU can easily be confused with pyoderma gangrenosum, which can be detrimental, since the 2 diseases require a completely different treatment strategy.


Subject(s)
Arteriolosclerosis/complications , Calciphylaxis/complications , Ischemia/complications , Leg Ulcer/pathology , Leg Ulcer/therapy , Leg/blood supply , Skin Transplantation/methods , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Antihypertensive Agents/therapeutic use , Arteriolosclerosis/pathology , Calciphylaxis/pathology , Cohort Studies , Combined Modality Therapy , Debridement/methods , Female , Humans , Hypertension/complications , Hypertension/diagnosis , Ischemia/pathology , Leg Ulcer/physiopathology , Male , Middle Aged , Necrosis/pathology , Pain Measurement , Prognosis , Retrospective Studies , Severity of Illness Index , Subcutaneous Tissue/pathology , Treatment Outcome , Wound Healing/physiology
16.
J Dtsch Dermatol Ges ; 8(11): 897-9, 2010 Nov.
Article in English, German | MEDLINE | ID: mdl-20163504

ABSTRACT

Furniture components can cause contact allergies. In the last years several cases of eczema after sofa contact have been reported. Typically the skin lesions develop on the back, the buttocks, the dorsal aspects of the thighs and arms and are often very resistant to topical corticoid therapy. Dimethylfumarate (DMF) is postulated to be the causative agent for this Type IV hypersensitivity reaction. DMF is an antimicrobial substance, which is used in asian upholstered furniture industry amongst others. We report the case of a 65-year old patient with generalised severely itching maculopapular, partly eczematous skin lesions on the buttocks, back, abdomen and arms. The resistance to therapy, several relapses after discharge from hospital as well as the detailed history lead us to the tentative diagnosis. The sofa dermatitis was proven by positive patch testing with furniture material and dimethylfumarate.


Subject(s)
Dermatitis, Contact/diagnosis , Dermatitis, Contact/etiology , Fumarates/toxicity , Interior Design and Furnishings , Aged , Dermatitis, Contact/therapy , Dimethyl Fumarate , Humans , Male
19.
J Biol Chem ; 281(24): 16354-60, 2006 Jun 16.
Article in English | MEDLINE | ID: mdl-16608840

ABSTRACT

Cladosporium herbarum is an important allergenic fungal species that has been reported to cause allergic diseases in nearly all climatic zones. 5-30% of the allergic population displays IgE antibodies against molds. Sensitization to Cladosporium has often been associated with severe asthma and less frequently with chronic urticaria and atopic eczema. However, no dominant major allergen of this species has been found so far. We present cloning, production, and characterization of NADP-dependent mannitol dehydrogenase of C. herbarum (Cla h 8) and show that this protein is a major allergen that is recognized by IgE antibodies of approximately 57% of all Cladosporium allergic patients. This is the highest percentage of patients reacting with any Cladosporium allergen characterized so far. Cla h 8 was purified to homogeneity by standard chromatographic methods, and both N-terminal and internal amino acid sequences of protein fragments were determined. Enzymatic analysis of the purified natural protein revealed that this allergen represents a NADP-dependent mannitol dehydrogenase that interconverts mannitol and d-fructose. It is a soluble, non-glycosylated cytoplasmic protein. Two-dimensional protein analysis indicated that mannitol dehydrogenase is present as a single isoform. The cDNA encoding Cla h 8 was cloned from a lambda-ZAP library constructed from hyphae and spores. The recombinant non-fusion protein was expressed in Escherichia coli and purified to homogeneity. Its immunological and biochemical identity with the natural protein was shown by enzyme activity tests, CD spectroscopy, IgE immunoblots with sera of patients, and by skin prick testing of Cladosporium allergic patients. This protein therefore is a new major allergen of C. herbarum.


Subject(s)
Alcohol Oxidoreductases/metabolism , Cladosporium/immunology , Allergens/chemistry , Amino Acid Sequence , Base Sequence , Circular Dichroism , Cladosporium/chemistry , Cytoplasm/metabolism , Electrophoresis, Gel, Two-Dimensional , Humans , Immunoglobulin E/chemistry , Mannitol Dehydrogenases , Molecular Sequence Data , Oligonucleotides/chemistry , Protein Structure, Tertiary , Skin Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...